We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Healthcare 17.83%
3 Consumer Discretionary 11.58%
4 Financials 10.55%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQUA
601
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$6.77M 0.02%
250,875
+84,238
+51% +$2.09M
IVV icon
602
iShares Core S&P 500 ETF
IVV
$837B
$6.76M 0.02%
18,018
+642
+4% +$229K
FDS icon
603
Factset
FDS
$9.85B
$6.73M 0.02%
20,231
-689
-3% -$228K
TRP icon
604
TC Energy
TRP
$63.6B
$6.71M 0.02%
164,710
+34,489
+26% +$1.47M
AIMC
605
DELISTED
Altra Industrial Motion Corp
AIMC
$6.71M 0.02%
120,993
ARW icon
606
Arrow Electronics
ARW
$10.8B
$6.7M 0.02%
68,900
+52,600
+323% +$4.65M
INGR icon
607
Ingredion
INGR
$6.25B
$6.69M 0.02%
84,991
-29,450
-26% -$2.27M
BTG icon
608
B2Gold
BTG
$6.9B
$6.66M 0.02%
1,189,400
-335,500
-22% -$2.05M
AJG icon
609
Arthur J. Gallagher & Co
AJG
$63.6B
$6.6M 0.02%
53,387
+13,970
+35% +$1.59M
RGEN icon
610
Repligen
RGEN
$9.86B
$6.55M 0.02%
34,200
+1,400
+4% +$255K
CHNG
611
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$6.49M 0.02%
348,167
CSGS
612
DELISTED
CSG Systems International
CSGS
$6.47M 0.02%
143,600
ITGR icon
613
Integer Holdings
ITGR
$4.29B
$6.41M 0.02%
79,000
-3,500
-4% -$246K
RUN icon
614
Sunrun
RUN
$2.02B
$6.41M 0.02%
+92,444
New +$5.74M
CNST
615
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$6.41M 0.02%
222,450
+32,754
+17% +$824K
NTRA icon
616
Natera
NTRA
$50.6B
$6.38M 0.02%
64,150
-99,450
-61% -$8.31M
B
617
Barrick Mining
B
$70.3B
$6.38M 0.02%
280,091
-1,131,977
-80% -$28.7M
COR icon
618
Cencora
COR
$61.7B
$6.36M 0.02%
65,080
-2,013
-3% -$201K
FOXF icon
619
Fox Factory Holding Corp
FOXF
$805M
$6.34M 0.02%
60,000
MOH icon
620
Molina Healthcare
MOH
$10.8B
$6.29M 0.02%
29,569
-31,180
-51% -$6.44M
ABEV icon
621
Ambev
ABEV
$46.6B
$6.27M 0.02%
2,049,188
+4,475
+0.2% +$12.1K
EPR icon
622
EPR Properties
EPR
$4.5B
$6.25M 0.02%
192,409
ACH
623
Accendra Health
ACH
$85.4M
$6.24M 0.02%
230,700
+2,600
+1% +$66.9K
DOW icon
624
Dow Inc
DOW
$21.6B
$6.24M 0.02%
112,391
+10,936
+11% +$565K
SWAV
625
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$6.2M 0.02%
59,800
-52,900
-47% -$4.58M

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.